K. Paciaroni, “THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.: Dual Myeloid Disorder Treated with Two Drug Association”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025023, Feb. 2025.